Site Management/Investigator Payments Featured Articles
-
How To Turn Your Clinical Supply Chain Pandemic Learnings Into New Best Practices
3/10/2022
Pivoting, navigating, and problem solving in real time during the pandemic has led to many real-time lessons that have evolved into adapted best practices in the global clinical supply space. This article discusses the new demand curve, packaging operations, IRT considerations, and more.
-
Essential Elements Of Clinical Trial Sponsor Oversight For Mitigating Scientific Misconduct & Fraud
2/10/2022
Sponsor companies are responsible for the protection of human subjects and the quality and integrity of their data when it comes to the conduct of clinical investigations. This responsibility sounds daunting, but this article shares how to break down key elements of CRO oversight in a holistic way.
-
The Top 4 Clinical Research Site Enrollment Challenges And How To Solve Them
1/28/2022
Here are the top four site enrollment challenges and how to solve them in order for research to stay on time and on budget.
-
Should We Build Or Break Skill Silos In Clinical Trials?
1/25/2022
We tend to forget to talk about the knowledge and skill silos in clinical trials that we have built over the years. This article describes how the industry got to where we are with narrow specialization and recommends 5 strategies to break skill silos.
-
SIVs: Identify Skill Gaps Before Retraining
1/24/2022
Discover how a focus on evaluating protocol-specific training already conducted at a research site could hold a key to better focusing site initiation visits (SIVs) on critical factors and reducing the amount of time spent on these meetings.
-
Maximizing Site Enrollment With Better Protocol Comprehension
12/20/2021
Sponsors and CROs trying to improve enrollment often overlook the most essential stakeholder in the process — the investigative sites. Get several strategies for improving existing and developing protocols.
-
Gilead Sciences’ Innovative Approach To An HIV Clinical Trial
12/16/2021
When Gilead launched its Phase 3 study of investigational lenacapavir for PrEP, the team recognized that any clinical pathways intent on introducing new PrEP options must commit to addressing and effectively bridging existing gaps if we strive to drive real change in HIV prevention. This is the story of how Gilead approached trial design in an innovative manner.
-
Helping Your Research Site Go Paperless
12/8/2021
In the available article, read about the three common concerns about going paperless with clinical research.
-
How Remote Site Access Is Changing Clinical Operations
11/2/2021
How can always-on remote site access benefit your research organization? Read about these benefits and the importance of reliable, efficient remote site access.
-
Clinical Trials: Envisioning A Future Where Technology Expedites Your Investigational Product’s Labeling & Shipment
10/14/2021
When you assess other industries and companies like Amazon, Tesla, and Coca Cola, each has a commanding use of innovation and technology to ensure they have what they need, when they need it, and that how it gets from pick-to-pack is swift and error-free. Some clinical trials operatives may say, “but they are not required to follow the GMPs” or “we work in a highly regulated industry.” To those, I say: that's an excuse.